Theratechnologies Inc.

NASDAQ: THTX · Real-Time Price · USD
3.22
-0.01 (-0.31%)
At close: Aug 14, 2025, 3:59 PM
3.21
-0.31%
After-hours: Aug 14, 2025, 06:26 PM EDT

Theratechnologies Income Statement

Financials in USD. Fiscal year is December - November.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Nov 30, 2024 Nov 30, 2023 Nov 30, 2022 Nov 30, 2021
Revenue
85.87M 81.76M 80.06M 69.82M
Cost of Revenue
20.45M 19.64M 26.28M 23.26M
Gross Profit
65.42M 62.13M 53.78M 46.56M
Operating Income
8.17M -10.63M -39.91M -25.24M
Interest Income
1.49M n/a 316K 195K
Pretax Income
-6.3M -23.54M -46.79M -31.66M
Net Income
-8.31M -23.96M -47.24M -31.73M
Selling & General & Admin
40.27M 42.39M 56.75M 43.52M
Research & Development
16.97M 30.37M 36.94M 28.27M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
57.24M 72.76M 93.69M 71.8M
Interest Expense
10.42M 10.55M 6.5M 5.66M
Selling & Marketing Expenses
25.42M 26.77M 39.39M 28.91M
Cost & Expenses
77.69M 92.39M 119.97M 95.06M
Income Tax Expense
2M 421K 443K 63K
Shares Outstanding (Basic)
49.36M 73.08M 95.25M 92.35M
Shares Outstanding (Diluted)
49.36M 73.08M 95.25M 92.35M
EPS (Basic)
-0.17 -0.33 -0.5 -0.34
EPS (Diluted)
-0.17 -0.33 -0.5 -0.34
EBITDA
6.88M -8.91M -27.83M -17.25M
EBIT
4.12M -12.22M -40.3M -26M
Depreciation & Amortization
2.76M 3.31M 12.47M 8.75M